Taro Pharmaceutical Industries Ltd (NYSE:TARO)

118.86
Delayed Data
As of Jun 21
 -0.99 / -0.83%
Today’s Change
93.01
Today|||52-Week Range
128.46
+13.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues862.9M950.8M879.4M661.9M
 
 
 
 
 
Cost of Goods Sold170.6M154.9M193.0M181.9M
 
 
 
 
 
Depreciation And Amortization15.8M14.8M14.8M16.5M
 
 
 
 
 
 
Operating ExpensesGross Income676.6M781.0M671.5M463.5M
 
 
 
 
 
General Expenses153.2M163.5M156.3M158.6M
 
 
 
 
 
Research And Development65.5M71.2M70.6M70.4M
 
 
 
 
 
Total Operating Expenses339.5M333.3M364.2M357.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income523.4M617.5M515.2M304.9M
 
 
 
 
 
Extraordinary Credit4.2M0.000.000.00
 
 
Extraordinary Charge---3.0M-276.0K-1.9M
 
 
 
 
Interest Expense On Debt928.0K473.0K0.00--
 
 
 
Other Expenses44.4M9.7M31.2M-30.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income581.7M636.8M560.8M292.4M
 
 
 
 
 
Income Taxes-96.1M-95.3M-103.8M-82.0M
 
 
 
 
 
Minority Interest-577.0K-339.0K-310.0K-1.1M
 
 
 
 
 
Discontinued Operations-787.0K-236.0K-352.0K-335.0K
 
 
 
 
 
Net Income484.3M540.9M456.4M211.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.8M42.8M41.3M40.2M
 
 
 
 
 
Shares To Calculate EPS Diluted42.8M42.8M41.3M40.2M
 
 
 
 
 
 
Earnings Per ShareEPS$11.31$12.62$11.05$5.26
 
 
 
 
 
EPS Diluted$11.31$12.63$11.05$5.26